Cellular Senescence Biomarker To Predict Postoperative AKI - July 22, 2024

Created: September 18, 2024

Last Updated: September 18, 2024

Contributor(s):

Judson B. Williams MD, MHS

Executive Medical Director, Heart and Vascular, WakeMed Health and Hospitals

Editor(s):

Cheryl Crisafi MSN, RN

Summary

Learn about the use of Cellular Senescence biomarkers to predict postoperative acute kidney injury (AKI). Traditionally, healthcare providers use age, GFR, and creatinine to predict postoperative AKI risk. Dr. Williams shares how the use of Cellular Senescence biomarkers provides insight into the role of assessing the biological age of cells to identify cardiac surgery patients at risk for postoperative AKI.

The ERAS Cardiac Multidisciplinary Team Meeting is a collaborative opportunity for ERAS team members from around the world to share best practices, experiences, and expertise while discussing current ERAS topics. The meeting is open to anyone interested in learning more about ERAS or wanting to share their knowledge with others. A diverse perspective on perioperative care is gained through cross-disciplinary discussion between coordinators, nurses, physicians, physiotherapists, and other members of the healthcare team.

Meetings are held virtually, at regularly scheduled intervals. Invitations for upcoming meetings and links to join are distributed via email. If you are interested in participating in one of our ERAS Cardiac Multidisciplinary Team Meetings or would like additional information, please email us at: team@erascardiac.org.

________________________________________________________________________________________________________________________________

ERAS Cardiac VTC Disclaimer:

The VTC, and all included content, is intended to inform ERAS Cardiac Members in a multitude of topics related to enhanced recovery. The information included has been provided by other enhanced recovery experts and should be used for educational purposes only. It is not intended to describe, recommend, or suggest any specific medical practice or intervention, nor should it be considered as formal medical advice or consultation. The ERAS Cardiac Society cannot guarantee that the information on the VTC is accurate or complete in every respect. Therefore, ERAS Cardiac Society is not responsible for any errors or omissions in the content, or medical results that occur with the application of the information obtained while using the VTC. All healthcare professionals should continue to use sound clinical judgment and prescribe therapies based on the best medical knowledge at their disposal.

Educational Materials

Cellular Senescence Biomarker To Predict Postoperative AKI
Learn about the use of Cellular Senescence biomarkers to predict postoperative acute kidney injury (AKI).

References:

None Available At This Time.

Visit our Publications Registry for papers related to this topic.

Next